Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Sprenger

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|February 11, 2021
Efficient <i>In Silico</i> Saturation Mutagenesis of a Member of the Caspase Protease FamilyChristoph Öhlknecht, Sonja Katz, Christina Kröß, et al.
Proteins|May 21, 2020
Enhancing the promiscuity of a member of the Caspase protease family by rational designChristoph Öhlknecht, Drazen Petrov, Petra Engele, et al.
Npj Viruses|February 23, 2026
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvirLaura Krismer, Helge Schöppe, Stefanie Rauch, et al.
Npj Viruses|June 27, 2024
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvirLaura Krismer, Helge Schöppe, Stefanie Rauch, et al.
The Journal of Biological Chemistry|August 21, 2021
PROFICS: A bacterial selection system for directed evolution of proteasesChristina Kröß, Petra Engele, Bernhard Sprenger, et al.
New Biotechnology|August 4, 2022
CASPON platform technology: Ultrafast circularly permuted caspase-2 cleaves tagged fusion proteins before all 20 natural amino acids at the N-terminusNico Lingg, Christina Kröß, Petra Engele, et al.
Antiviral Research|July 25, 2024
Highly specific SARS-CoV-2 main protease (M<sup>pro</sup>) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based systemStefanie Rauch, Francesco Costacurta, Helge Schöppe, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
A comprehensive study of SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.
Plos Pathogens|September 11, 2024
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|February 11, 2021
Efficient <i>In Silico</i> Saturation Mutagenesis of a Member of the Caspase Protease FamilyChristoph Öhlknecht, Sonja Katz, Christina Kröß, et al.
Proteins|May 21, 2020
Enhancing the promiscuity of a member of the Caspase protease family by rational designChristoph Öhlknecht, Drazen Petrov, Petra Engele, et al.
Npj Viruses|February 23, 2026
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvirLaura Krismer, Helge Schöppe, Stefanie Rauch, et al.
Npj Viruses|June 27, 2024
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvirLaura Krismer, Helge Schöppe, Stefanie Rauch, et al.
The Journal of Biological Chemistry|August 21, 2021
PROFICS: A bacterial selection system for directed evolution of proteasesChristina Kröß, Petra Engele, Bernhard Sprenger, et al.
New Biotechnology|August 4, 2022
CASPON platform technology: Ultrafast circularly permuted caspase-2 cleaves tagged fusion proteins before all 20 natural amino acids at the N-terminusNico Lingg, Christina Kröß, Petra Engele, et al.
Antiviral Research|July 25, 2024
Highly specific SARS-CoV-2 main protease (M<sup>pro</sup>) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based systemStefanie Rauch, Francesco Costacurta, Helge Schöppe, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
A comprehensive study of SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.
Plos Pathogens|September 11, 2024
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.
Pageof 1